Get Our FREE Newsletter

Sign Up

Attorney General Merrick Garland: 52% of federal inmates in America are now vaccinated for COVID-19

Spread the love

Reuters Videos

Large study to test COVID vaccine in kids -Pfizer

Pfizer on Tuesday said it will begin testing its COVID-19 vaccine in a larger group of children under the age of 12 – but at a lower dose. The study will involve up to 4,500 kids in the U.S., Finland, Poland and Spain. Based on safety, tolerability and the immune response generated by 144 children in a phase 1 study of the two-dose vaccine, Pfizer said it will now test a lower dose on the younger kids. That is: 10 micrograms for 5-11 year-olds, and 3 micrograms for the age group of 6 months to five years of age. Currently, those over 12-years-old in the U.S, Canada, and Europe are receiving the same dose of the Pfizer-BioNTech vaccine as adults – 30 micrograms. Top U.S. infectious disease expert, Dr. Anthony Fauci on Tuesday said decreasing doses in trials on younger kids makes sense:“The idea of when you are going from an adult trial with adult doses – we do standard, this isn’t anything unusual, it’s called an age de-escalation and a dose de-escalation study. (flash) And when you get down to the younger children it is not at all unusual to diminish the dose.” According to the CDC, nearly 7 million teens have received at least one dose of the vaccine in the United States. And health experts say inoculating children is a critical step in taming the COVID-19 pandemic.

This post was originally published on this site